2Suppliers
0Customers
2Debt Items
0Related Chains
Decoy Therapeutics Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| CPRIT |
CPRIT |
90%
|
The Company is obligated to make revenue-sharing payments to CPRIT with respect to net sales of any product covered by the contract |
| UNIVERSITY-OF-UTAH-RESEARCH-FOUNDATION |
UNIVERSITY-OF-UTAH-RESEARCH-FOUNDATION |
90%
|
The Company entered into a license agreement with the University of Utah, under which, the Company acquired license to LSD 1 |
Decoy Therapeutics Inc. Customers
No clients on recordNo downstream customers found in our database for Decoy Therapeutics Inc..
Decoy Therapeutics Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| DCOY-DEBT-9040 |
Warrants outstanding: 142711 |
90%
|
xbrl warrant detail from xbrl 2025-12-31. |
| DCOY-DEBT-9041 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2020-12-31. |
Decoy Therapeutics Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Decoy Therapeutics Inc..
Decoy Therapeutics Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| DCOY-OWNER-WARBERG-ASSET-MANAGEMENT-LLC |
Warberg Asset Management LLC |
90%
|
13F overlay lists Warberg Asset Management LLC as top holder; 9 tracked holders. |
Decoy Therapeutics Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
